Ventricular Assist Devices – our new study reveals trends, R&D progress, and predicted revenues Where is the VAD market heading? If you are involved in this sector you must read this brand new report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.
Discover How to Stay Ahead Our 154-page report provides 104 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing VAD market. See how to exploit the opportunities.
Forecasts to 2027 and other analyses reveal the commercial prospects • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares. • You find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets Along with revenue prediction for the overall world market, there are forecasts for 3 Product Types and 3 Applications.
Ventricular Assist Devices Market Forecasts to 2027, By Product Type • RVAD • LVAD • BiVAD
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 12 leading national markets: • North America: • The US • Mexico • Canada
• Europe: • Germany • France • The UK • Italy • Spain • Russia • Rest of Europe
• Asia Pacific: • Japan • China • India • Rest of Asia Pacific
• Rest of World: • Latin America • Middle East • Africa
The report also includes profiles and forecasts for some of the leading companies in the Ventricular Assist Device market, with a focus on the VAD segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.
Leading companies and the potential for market growth Overall world revenue for VAD will surpass $900m in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of heart disease, and increasing ageing population will increase sales to 2027.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the VAD Market report helps you In summary, our 154-page report provides you with the following knowledge: • Revenue forecasts to 2027 for the world Ventricular Assist Devices market and 2 different segmentations, with 3 product categories and 3 applications – discover the industry’s prospects, finding the most lucrative places for investments and revenues • Revenue forecasts to 2027 for 6 regional markets and 12 of the leading national markets – US, Mexico, Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Russia, • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the Ventricular Assist device market and leading companies. You find data, trends and predictions.
Get our report today Ventricular Assist Device (VAD) Market Forecast 2017-2027: Revenue Prospects by Product Type (LAVD, RVAD, BiVAD), Application (BTT & BTD Therapy, Destination Therapy, BTR Therapy) and Geography. Avoid missing out – get our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Ventricular Assist Device (VAD) Market Definition 1.2 Methodology 1.2.1 Primary Research 1.2.2 Secondary Research 1.2.3 Market Evaluation & Forecasting Methodology 1.3 Ventricular Assist Device (VAD) Report Structure 1.4 Why You Should Read This Report 1.5 How this Report Delivers 1.6 Key Questions Answered by This Analytical Report Include: 1.7 Who is This Report For? 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2. Introduction to the Ventricular Assist Device (VAD) Market 2.1 The Role and Function of VADs 2.2 What is a Ventricular Assist Device (VAD)? 2.3 Type of VADs? 2.4 Brief History of VADs 2.5 Key VAD products
3. Market Overview Global Ventricular Assist Device (VAD) Market, Qualitative Analysis 3.1 Porter’s Five Forces Analysis 3.2 Porter’s Five Forces Analysis of Ventricular Assist Device (VAD) Market 3.2.1 Rivalry among Competitors [High] 3.2.2 Threat of New Entrants [Medium] 3.2.3 Power of Suppliers [Low] 3.2.4 Power of Buyers [Medium] 3.2.5 Threat of Substitutes [Medium] 3.3 Pipeline Analysis 3.3.1 Key Information about Pipeline Products 3.3.2 ReliantHeart HeartAssist 5 VAD System 3.3.3 HeartMate III LVAS 3.3.4 HeartMate PHP 3.4 Patent Analysis 3.5 Global Ventricular Assist Devices (VAD) Market Dynamics 3.5.1 Unavailability of Heart Donors 3.5.2 Technological Advancements 3.5.3 Rising incident of Heart Failure 3.5.4 Favourable Reimbursement Policies 3.6 Global Ventricular Assist Devices (VAD) Market Challenges 3.6.1 Existence of Alternative Treatments 3.6.2 Complications Associated with VAD Implantation 3.6.3 Rise in Number of Product Recalls 3.6.4 Low Adoption Rate in Emerging Countries 3.7 Global Ventricular Assist Devices (VAD) Market Opportunities 3.7.1 Lucrative opportunities in emerging economies 3.8 Global Ventricular Assist Devices (VAD) Market Trends 3.8.1 Increased adoption of VADs for BTT Therapy 3.8.2 Growing Merger & Acquisitions 3.8.3 Increase in Clinical Trials 3.8.4 Rising Number of Cardiac Centres in the USA
4. Global Ventricular Assist Device (VAD) Market by Type Forecast 2017-2027 4.1 Left Ventricular Assist Device (LVAD) 4.1.1 Global Left Ventricular Assist Device (LVAD) Trends 4.1.2 Global Left Ventricular Assist Device (LVAD) Growth Factors 4.2 Right Ventricular Assist Device (RVAD) 4.2.1 Global Right Ventricular Assist Device (RVAD) Trends 4.2.2 Global Right Ventricular Assist Device (RVAD) Growth Factors 4.3 Bi-Ventricular Assist Device (BiVAD) 4.3.1 Global Bi-Ventricular Assist Device (BiVAD) Trends 4.3.2 Global Bi-Ventricular Assist Device (BIVAD) Growth Factors
5. Global VAD Market, By Application, Forecast 2017-2027 5.1 BTT Therapy & BTD Therapy 5.2 Destination Therapy 5.3 BTR Therapy
6. Leading Regional Global Ventricular Assist Device (VAD) Market Forecast 2017-2027 6.1 North America Ventricular Assist Device (VAD) Market Analysis 6.1.1 USA VAD Market Analysis 6.1.1.1 USA Ventricular Assist Devices Market Forecasts 2017-2027 6.1.2 Mexico VAD Market Analysis 6.1.2.1 Mexico Ventricular Assist Devices Market Forecasts 2017-2027 6.1.3 Canada VAD Market Analysis 6.1.3.1 Canada Ventricular Assist Devices Market Forecasts 2017-2027 6.2 Europe Ventricular Assist Device (VAD) Market Analysis 6.2.1 Europe Ventricular Assist Device (VAD) Market Forecast 6.2.2 U.K. Ventricular Assist Device (VAD) Market Analysis 6.2.2.1 U.K. Ventricular Assist Devices Market Forecasts 2017-2027 6.2.3 France Ventricular Assist Device (VAD) Market Analysis 6.2.3.1 France Ventricular Assist Devices Market Forecasts 2017-2027 6.2.4 Germany Ventricular Assist Device (VAD) Market Analysis 6.2.4.1 Germany Ventricular Assist Devices Market Forecasts 2017-2027 6.2.5 Italy Ventricular Assist Devices Market Forecasts 2017-2027 6.2.6 Spain Ventricular Assist Devices Market Forecasts 2017-2027 6.2.7 Russia Ventricular Assist Devices Market Forecasts 2017-2027 6.2.8 Rest of Europe Ventricular Assist Devices Market Forecasts 2017-2027 6.3 Asia-Pacific Ventricular Assist Device (VAD) Market Analysis 6.3.1 Asia-Pacific Ventricular Assist Device (VAD) Market Forecast 6.3.2 India Ventricular Assist Device (VAD) Market Analysis 6.3.2.1 India Ventricular Assist Devices Market Forecasts 2017-2027 6.3.3 China Ventricular Assist Device (VAD) Market Analysis 6.3.3.1 China Ventricular Assist Devices Market Forecasts 2017-2027 6.3.4 Japan Ventricular Assist Device (VAD) Market Analysis 6.3.4.1 Japan Ventricular Assist Devices Market Forecasts 2017-2027 6.3.5 Other Asia-Pacific Ventricular Assist Device (VAD) Market Analysis 6.3.5.1 Other Asia-Pacific Ventricular Assist Devices Market Forecasts 2017-2027 6.4 Rest of the World Ventricular Assist Device (VAD) Market Analysis 6.4.1 Rest of the World Ventricular Assist Device (VAD) Market Forecast 6.4.2 Latin America Ventricular Assist Device (VAD) Market Analysis 6.4.2.1 Latin America Ventricular Assist Devices Market Forecasts 2017-2027 6.4.3 Middle East Ventricular Assist Device (VAD) Market Analysis 6.4.3.1 Middle East Ventricular Assist Devices Market Forecasts 2017-2027 6.4.4 Africa Ventricular Assist Device (VAD) Market Analysis 6.4.4.1 Africa Ventricular Assist Devices Market Forecasts 2017-2027
7. Leading Companies in Global Ventricular Assist Device (VAD) Market 7.1 Abiomed, Inc. 7.1.1 Company Introduction 7.1.2 Abiomed Business Segments: 7.1.3 Abiomed Business Performance: 7.1.4 Abiomed Revenue, 2013-2015 7.1.5 Abiomed Research and Developments: 7.1.6 SWOT Analysis of Abiomed Inc. 7.2 Berlin Heart GmbH 7.2.1 Company Introduction 7.2.2 Berlin Heart GmbH Business Segments: 7.2.3 Berlin Heart GmbH Research and Developments: 7.2.4 SWOT Analysis of Berlin Heart GmbH 7.3 HeartWare International, Inc. 7.3.1 Company Introduction 7.3.2 HeartWare Business Segments: 7.3.3 HeartWare Business Performance: 7.3.4 HeartWare Revenue, 2013-2015 7.3.5 Key Strategic Moves & Developments 7.3.6 SWOT Analysis of HeartWare 7.4 Jarvik Heart, Inc. 7.4.1 Company Introduction 7.4.2 Jarvik heart: Business Segments 7.4.3 Key Strategic Moves & Developments 7.4.4 Jarvik heart: SWOT Analysis 7.5 LivaNova PLC 7.5.1 Company Introduction 7.5.2 LivaNova Business Segments 7.5.3 LivaNova: Business Performance 7.5.4 LivaNova: net sales, 2013–2015 ($Million) 7.5.5 LivaNova: SWOT Analysis 7.6 ReliantHeart, Inc. 7.6.1 ReliantHeart: Company Overview 7.6.2 ReliantHeart: Operating Business Segments 7.6.3 ReliantHeart: Key Strategic Developments 7.6.4 ReliantHeart: SWOT Analysis 7.7 Other Companies of Interest in the VAD Market
8. Conclusions 8.1 Current Leading Ventricular Assist Device Segments 8.2 Leading Ventricular Assist Devices Companies 8.3 Leading Regional Markets 8.4 Emerging Ventricular Assist Devices Markets 8.5 The Future of the Ventricular Assist Devices Market?
9. Glossary 9.1 VAD Patent Registrations 2010-2017 Visiongain Report Sales Order Form Appendix A About Visiongain Appendix B Visiongain report evaluation form
List of Figures Figure 1.1 Global Ventricular Assist Device Market Segmentation Overview, 2017 Figure 2.1 Global VAD Market Product Overview, 2017 Figure 3.1 Market segmentation for Ventricular Assist Device (VAD) Figure 3.2 Porter’s Five Forces Analysis of Ventricular Assist Device (VAD) Market, 2017-2027 Figure 3.3 Patent Analysis of Ventricular Assist Device (VAD) Market, by region, 2010-2017 Figure 3.4 Patent Analysis of Ventricular Assist Device (VAD) Market, by Year, 2010-2017 Figure 3.5 Patent Analysis of Ventricular Assist Device (VAD) Market, by region, 2010-2017 Figure 3.6 Impact of Drivers Figure 3.7 Impact of Challenges Figure 3.8 Impact of Trends Figure 4.1 Global Ventricular Assist Device (VAD) Market Forecasts, by Product, Market Share (%), 2016 Figure 4.2 Ventricular Assist Devices Market, by Product, Forecast ($million) 2016-2027 Figure 4.3 Global Ventricular Assist Device (VAD) Market Forecasts By Type ($m, AGR%) 2017-2027 Figure 4.4 Global Left Ventricular Assist Device (LVAD) Market Forecasts ($m, AGR%) 2017-2027 Figure 4.5 Global Right Ventricular Assist Device (RVAD) Market Forecasts ($m, AGR%) 2017-2027 Figure 4.6 Global Bi-Ventricular Assist Device (BIVAD) Market Forecasts ($m, AGR%) 2017-2027 Figure 5.1 Global Ventricular Assist Device (VAD) Market Figure 5.2 Global Ventricular Assist Device Market Forecast, by Application, Market Share (%), 2016 Figure 5.3 Global Ventricular Assist Device Market Forecast, by Application, ($million) 2016-2027 Figure 5.4 Global Ventricular Assist Device (VAD) Market Forecasts By Application ($m, AGR%) 2017-2027 Figure 5.5 Global BTT Therapy & BTD Therapy Market Forecasts ($m, AGR%) 2017-2027 Figure 5.6 Global Destination Therapy Market Forecasts ($m, AGR%) 2017-2027 Figure 5.7 Global BTR Therapy Market Forecasts ($m, AGR% CAGR%) 2017-2027 Figure 6.1 Global Ventricular Assist Device Market Forecast, by Geography, Market Share (%), 2016 Figure 6.2 Global Ventricular Assist Device Market Forecast, by Geography,($million) 2016-2027 Figure 6.3 North America Ventricular Assist Devices Market, by Country, Market Share (%), 2016 Figure 6.4 North America Ventricular Assist Devices Market, by Country, ($million) 2016-2027 Figure 6.5 USA Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%)2017-2027 Figure 6.6 Mexico Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.7 Canada Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.8 Europe Ventricular Assist Devices Market, by Country, Market Share (%), 2016 Figure 6.9 Europe Ventricular Assist Devices Market, by Country, ($million) 2016-2027 Figure 6.10 U.K. Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.11 France Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.12 Germany Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.13 Italy Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.14 Spain Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.15 Russia Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.16 Rest of Europe Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.17 Asia-Pacific Ventricular Assist Devices Market, by Country, Market Share (%), 2016 Figure 6.18 Asia-Pacific Ventricular Assist Devices Market, by Country, ($million) 2016-2027 Figure 6.19 India Ventricular Assist Devices Market Forecast($m, AGR% CAGR%) 2017-2027 Figure 6.20 China Ventricular Assist Devices Market Forecast($m, AGR% CAGR%) 2017-2027 Figure 6.21 Japan Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.22 Other Asia-Pacific Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.23 Rest of the World Ventricular Assist Devices Market, by Country, Market Share (%), 2016 Figure 6.24 Rest of the World Ventricular Assist Devices Market, by Country, ($million) 2016-2027 Figure 6.25 Latin America Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.26 Middle East Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 6.27 Africa Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027 Figure 7.1 Abiomed sales analysis, by business segments, 2013-2015, $m Figure 7.2 SWOT Analysis of Abiomed Inc. Figure 7.3 Berlin Heart SWOT analysis Figure 7.4 HeartWare sales analysis, by business segments, 2013-2015, $Mn Figure 7.5 HeartWare: Revenue by geography, 2015 (%) Figure 7.6 HeartWare SWOT analysis Figure 7.7 Jarvik heart SWOT analysis Figure 7.8 LivaNova sales analysis, by business segments, 2013-2015, $Mn Figure 7.9 LivaNova: revenue by business segments, 2015 (%) Figure 7.10 LivaNova: Revenue by geography, 2015 (%) Figure 7.11 LivaNova SWOT analysis Figure 7.12 ReliantHeart SWOT analysis
List of Tables Table 3.1 Snapshot of Pipeline for VADs Table 3.2 VAD Pipeline: ReliantHeart Assist Device Table 3.3 VAD Pipeline: HeartMate III LVAS Table 3.4 VAD Pipeline: HeartMate PHP Table 4.1 Global Ventricular Assist Device (VAD) Market Forecasts By Type ($mn, AGR% CAGR%) 2022-2027 Table 4.2 Global Left Ventricular Assist Device (LVAD) Market Forecasts ($m, AGR%) 2016-2027 Table 4.3 Global Right Ventricular Assist Device (RVAD) Market Forecasts ($m, AGR%) 2016-2027 Table 4.4 Global Bi-Ventricular Assist Device (BIVAD) Market Forecasts ($m, AGR%) 2016-2027 Table 5.1 Global Ventricular Assist Device (VAD) Market Forecasts By Application ($m, AGR%) 2022-2027 Table 5.2 Global BTT Therapy & BTD Therapy Market Forecasts ($m, AGR%) 2016-2027 Table 5.3 Global Destination Therapy Market Forecasts ($m, AGR%) 2016-2027 Table 5.4 Global BTR Therapy Market Forecasts ($m, AGR%) 2016-2027 Table 6.1 Global Ventricular Assist Device Market Forecast, by Geography ($m, AGR% CAGR%) 2016-2027 Table 6.2 North America Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027 Table 6.3 USA Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.4 Mexico Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.5 Canada Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.6 Europe Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027 Table 6.7 U.K. Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.8 France Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.9 Germany Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.10 Italy Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.11 Spain Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.12 Russia Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.13 Rest of Europe Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.14 Asia-Pacific Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027 Table 6.15 India Ventricular Assist Devices Market Forecasts ($m, AGR%, CAGR%) 2016-2027 Table 6.16 China Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.17 Japan Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.18 Other Asia-Pacific Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.19 Rest of the World Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027 Table 6.20 Latin America Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.21 Middle East Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 6.22 Africa Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027 Table 7.2 Abiomed Inc.: Recent Developments Table 7.4 Berlin Heart Gmbh: Recent Developments Table 7.6 HeartWare International Inc.: Recent Developments Table 7.7 Jarvik Heart Inc.: Company Snapshot Table 7.8 Jarvik Heart Inc.: Recent Developments Table 7.9 LivaNova Plc: Company Snapshot Table 7.10 LivaNova: operating segments Table 7.12 ReliantHeart: Recent Developments Table 7.1 Other Companies of Interest Table 7.13 Other Companies of Interest (continued) Table 8.1 Global Ventricular Assist Device (VAD) Market Overview, 2017-2027 Table 9.1 Patents Registered for Ventricular Assist Devices 2017 Table 9.2 Patents Registered for Ventricular Assist Devices 2016 Table 9.3 Patents Registered for Ventricular Assist Devices 2015 Table 9.4 Patents Registered for Ventricular Assist Devices 2014 Table 9.5 Patents Registered for Ventricular Assist Devices 2013 Table 9.6 Patents Registered for Ventricular Assist Devices 2012 Table 9.7 Patents Registered for Ventricular Assist Devices 2011 Table 9.8 Patents Registered for Ventricular Assist Devices 2010
Abbottdiabetescare.Com ABIOMED, Inc. Acelity LP, Inc. Advocate Health Care Network Alere, Inc. ALung Technologies Inc. American Heart Association Animas Corporation Asahi Kasei Medical Co. Ltd. Baxter International, Inc. Bodytel Gmbh Boston Scientific Corp. C.R. Bard, Inc. (New Jersey) Cedars-Sinai Cellnovo Group SA Circulite Inc. CryoLife, Inc. DexCom, Inc. Edwards Lifesciences Corp. Exactech, Inc. Guidant Corporation HeartWare International, Inc. Insulet Corp. International Society For Heart And Lung Transplantation Inc Jarvik Heart Inc. LeMaitre Vascular, Inc. Leviticus-Cardio Ltd. LivaNova Plc Mayo Foundation For Medical Education And Research Medtronic Plc Micromed Cardiovascular Inc. Nipro Corp. NuVasive, Inc. On-X Life Technologies Inc. Option Care Enterprises Inc. Organ Recovery Systems Inc. Peter Brasseler Holdings Llc Presence Prv Health Smith & Nephew Plc St. Jude Medical, Inc. Sunshine Heart, Inc. Teleflex, Inc. Terumo Corp. Terumo Heart Incorporated Thoratec Corporation United Network For Organ Sharing Valtech Cardio Ltd Visualase Inc. Walgreens Infusion Services Inc. World Heart Corporation Zimmer Biomet Holdings, Inc.
List of Organizations Advocate Health Care Network American Heart Association Food and Drug Administration (FDA) Health Canada Mayo Foundation For Medical Education And Research Ministry of Health, Labor, and Welfare (MHLW) National Health Service (UK) National Institutes of Health (NIH) Presence Prv Health United Nations United Network For Organ Sharing World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Ventricular Assist Device (VAD) Market Forecast 2017-2027
Download sample pages
Complete the form below to download your free sample pages for Ventricular Assist Device (VAD) Market Forecast 2017-2027
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global Clinical Trial Supplies market was valued at US$ 2,617.7 million in 2022 and is projected to grow at a CAGR of 9.32% during the forecast period 2023-2033.
The global Meningococcal Vaccines market was valued at US$3,268.6 million in 2022 and is projected to grow at a CAGR of 6.32% during the forecast period 2023-2033.
Visiongain Publishes Human Microbiome Market Report 2023-2033
The global Human Microbiome market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
